18 CHILDREN DIED IN UZBEKISTAN AFTER CONSUMING INDIAN PHARMA’S SYRUP

Thu 29 December 2022:

The government of Uzbekistan has launched an investigation into the deaths of 18 children who ingested Dok-1 Max, a cold and flu syrup manufactured by the Indian pharmaceutical Marion Biotech.

According to a report published on Wednesday by AKIpress, a criminal investigation has been launched against officials of the company importer Quramax Medical and the Research Center for Standardization of Medicines for the production and acquisition of low-quality medicines that resulted in the loss of lives.

According to the report, several people have been detained in connection with the deaths of these 18 children, and the suspects face between 10 and 15 years in prison.

The State Center for Expertise and Standardization of Medicines, Medical Devices and Medical Equipment of the Pharmaceutical Network Development Agency concluded that Dok-1 Max did not meet the requirements of normative documents, the report added.

It also said that previously, Uzbekistan’s health ministry had said that ethylene glycol was found in cold and flu syrup.

Marion Biotech has not responded to the above accusations

Based in Noida, Uttar Pradesh, the pharmaceutical makes medicines for anti-cold, pain and fever, food supplements and many other medicinal products.

According to Marion Biotech’s website, the Dok 1 Max syrup is a combination of three medical ingredients that reduce “symptoms associated with cold, flu, cough, fever and other infectious upper respiratory tract diseases which are accompanied by chill, cough and fever.”

According to the pharmaceutical, the ingredients of Dok-1 Max are usually well tolerated at the recommended doses. “Occasionally you may experience a skin rash, abdominal pain, increased blood pressure, dizziness and other allergic reactions,” according to the website.

This development in Uzbekistan comes months after at least 70 children in Gambia died as a result of acute kidney injury (AKI) caused by cough and cold syrups manufactured by Maiden Pharmaceuticals, another Indian company. Last week, a Gambia parliamentary committee recommended that the government take legal action against Maiden Pharmaceuticals for exporting contaminated drugs.

The panel also demanded that the company be blacklisted and its products be banned in domestic markets.

SOURCE: INDEPENDENT PRESS AND NEWS AGENCIES

___________________________________________________________________________________________________________________________________

FOLLOW INDEPENDENT PRESS:

TWITTER (CLICK HERE)
https://twitter.com/IpIndependent